Trials / Recruiting
RecruitingNCT05976412
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
Prospective Randomized Controlled Study on Precision Irradiation of Regional Lymph Node for Clinical High-risk pN0 Breast Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,355 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non blind, randomized controlled study, whose hypothesis was that chest wall/whole breast combined regional lymph node radiotherapy can improve the 5-year disease-free survival rate of clinical high-risk pN0 breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Regional lymph node radiotherapy | Regional lymph node radiotherapy |
| RADIATION | chest/whole breast irradiation | chest/whole breast irradiation |
Timeline
- Start date
- 2023-07-28
- Primary completion
- 2031-05-31
- Completion
- 2031-05-31
- First posted
- 2023-08-04
- Last updated
- 2023-08-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05976412. Inclusion in this directory is not an endorsement.